Description |
WEE1 G2 checkpoint kinase |
S-phase kinase associated protein 2 |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE
- 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE
- N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE
- 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione
- 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID
- 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide
- MK-1775
- Fostamatinib
|
|
Diseases |
|
|
GWAS |
- Cutaneous squamous cell carcinoma ( 32041948)
- Emphysema annual change measurement in smokers (adjusted lung density) ( 31324189)
- Platelet distribution width ( 32888494)
|
|
Interacting Genes |
22 interacting genes:
BRD8
BRSK1
BRSK2
BTRC
CASP3
CDCA3
CDK1
CDK2
CRK
CSNK2A1
ERRFI1
FBXW11
NEDD4
PIN1
PLK1
SKP2
SMAD3
SMURF1
YWHAB
YWHAG
YWHAQ
YWHAZ
|
64 interacting genes:
AKT1
BRAP
BRCA1
BTG1
BTG2
CCNA2
CCNE1
CCNT1
CDC14B
CDC34
CDH1
CDK2
CDK9
CDKN1A
CDKN1B
CDKN1C
CDT1
CEBPA
CHKA
CKS1B
CKS1BP7
CUL1
CUL4A
DDB1
DUSP1
E2F1
ELF4
EP300
ESR1
FZR1
GPS1
KPNA1
KPNA6
MEF2D
MTOR
MYB
MYBL2
MYC
NLK
ORC1
PAX8
PDCD4
PFDN1
PIM1
POLR2A
PSMD9
RAG2
RB1
RBL2
RND3
SIRT4
SIRT6
SKP1
SLC9A3R1
SMAD4
SQSTM1
TAL1
TCF3
TRIM21
UBB
VHL
WEE1
YWHAB
YY1
|
Entrez ID |
7465 |
6502 |
HPRD ID |
01907 |
03256 |
Ensembl ID |
ENSG00000166483
|
ENSG00000145604
|
Uniprot IDs |
P30291
Q86V29
|
A0A024R069
Q13309
|
PDB IDs |
1X8B
2IN6
2IO6
2Z2W
3BI6
3BIZ
3CQE
3CR0
5V5Y
5VC3
5VC4
5VC5
5VC6
5VD2
5VD4
5VD5
5VD7
5VD8
5VD9
5VDA
|
1FQV
1FS1
1FS2
1LDK
2ASS
2AST
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|